The best way to support affordable access to proven products is to make a submission on the Misuse of Drugs (Medical Cannabis) Amendment Bill by Wednesday 21 March 2018.


How to make a submission

Submissions can be sent via email to the Clerk of the Health Select Committee at: or you can make your submission on the Parliament website.

The NZ Drug Foundation have published a useful guide to making a submission on this particular bill. Read the NZ Drug Foundation’s guide to making a submission on this bill

There is also a general guide to making submissions available on the NZ Parliament website. Read the NZ Parliament general guide for making submissions (PDF 117KB)


What do you need to know?

  • Submissions are publicly released and published to the Parliament website, so be careful about what you share in your submission
  • If you wish to include information of a private or personal nature in your submission you should discuss this with the clerk of the committee before submitting.
  • If you wish to speak to your submission (called an Oral Submission), state this clearly in your written submission. You can do an Oral Submission even if you’re out of town via phone or video-call. You can also change your mind and decide not to speak to your submission even if you have said you would, but if you haven’t said you would like to and then change your mind, a time will not have been made for you to do so.
  • Draft regulations relating to the Act will be published after the submissions closing date. The regulations contain the detail of how the Act is interpreted and implemented by officials. Your submission should request the opportunity to make a supplementary submission once the draft regulations are made public.
  • Submissions close on Wednesday 21 March. 


The following point are the main recommendations from the submission being made by Hikurangi Group:

  1. Cannabidiol (CBD) is not defined as ‘an isomer of tetrahydrocannabinol’ (THC) under Schedule 2, Part 1, Clause 1 of the Act and should be treated the same as other non-THC cannabinoids. 
  2. Medical cannabis products should have a percentage restriction placed on the THC content as a proportion of total cannabinoids, as opposed to restricting the content of other cannabinoids.
  3. THC levels allowed for under different types of medicine control should be determined by independent science and included in regulations by the end of 2018.
  4. The legislation should explicitly allow for exports of pharmaceutical grade medical cannabis as bulk ingredients and finished products.
  5. People with old convictions for cannabis should be able to work in the industry under specific conditions specified in the regulations.
  6. Allow anyone who has the written endorsement of their doctor to use cannabis as medication and a nominated caregiver to provide the cannabis without prosecution.

Your submission could just include some of the points above, or whatever else you would like to say, it could include more detail or just the main points you want to make. Remember to state if you think you may want to present in person and that you would like to make a supplementary submission after the draft regulations are released in coming weeks.

Email your submission, including your name and contact details, to: or use the online form here

  • Click here to download a submission template. (MS Word)
  • Click here to see our full submission.